The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Diagnosis and management of NSAID‐Exacerbated Respiratory Disease (N‐ERD)—a EAACI position paper
Open accessAbstract
NSAID‐exacerbated respiratory disease (N‐ERD) is a chronic eosinophilic, inflammatory disorder of the respiratory tract occurring in patients with asthma and/or chronic rhinosinusitis with nasal polyps (CRS w NP), symptoms of which are exacerbated by NSAID s, including aspirin. Despite some progress in understanding of the pathophysiology of the syndrome, which affects 1/10 of patients with asthma and rhinosinusitis, it remains a diagnostic and therapeutic challenge. In order to provide evidence‐based recommendations for the diagnosis and management of N‐ERD, a panel of international experts was called by the EAACI Asthma Section. The document summarizes current knowledge on the pathophysiology and clinical presentation of N‐ERD pointing at significant heterogeneity of this syndrome. Critically evaluating the usefulness of diagnostic tools available, the paper offers practical algorithm for the diagnosis of N‐ERD. Recommendations for the most effective management of a patient with N‐ERD stressing the potential high morbidity and severity of the underlying asthma and rhinosinusitis are discussed and proposed. Newly described sub‐phenotypes and emerging sub‐endotypes of N‐ERD are potentially relevant for new and more specific (eg, biological) treatment modalities. Finally, the document defines major gaps in our knowledge on N‐ERD and unmet needs, which should be addressed in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fokkens, W. J., Lund, V. J., Mullol, J., Bachert, C., Alobid, I., Baroody, F., Cohen, N., Cervin, A., Douglas, R., Gevaert, P., et al. (2012) · Rhinology journal · doi:10.4193/rhino12.000 · Cited by 2,387
Self-citationChronic rhinosinusitis in Europe - an underestimated disease. A GA2LEN study
Hastan, D., Fokkens, W. J., Bachert, C., Newson, R. B., Bislimovska, J., Bockelbrink, A., Bousquet, P. J., Brozek, G., Bruno, A., Dahlén, S. E., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02646.x · Cited by 1,112
Self-citationIntolerance to Aspirin: Clinical Studies and Consideration of its Pathogenesis
SAMTER, M., & BEERS, R. F. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-68-5-975 · Cited by 839
Bachert, C., Mannent, L., Naclerio, R. M., Mullol, J., Ferguson, B. J., Gevaert, P., Hellings, P., Jiao, L., Wang, L., Evans, R. R., et al. (2016) · JAMA · doi:10.1001/jama.2015.19330 · Cited by 794 · cited 1×
“Mepolizumab, an anti‐IL‐5 monoclonal antibody that has been approved for severe eosinophilic asthma, has been shown in two studies to decrease nasal polyposis,(60,71) and dupilumab, the IL‐4Rα antagonist that blocks both IL‐4 and IL‐13 signaling, has also been shown to decrease nasal polyps burden.(61) New biologicals…”
BackgroundSelf-citationThe ENFUMOSA Study Group (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00261903 · Cited by 759
Mepolizumab, a humanized anti–IL-5 mAb, as a treatment option for severe nasal polyposis
Gevaert, P., Van Bruaene, N., Cattaert, T., Van Steen, K., Van Zele, T., Acke, F., De Ruyck, N., Blomme, K., Sousa, A. R., Marshall, R. P., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.07.056 · Cited by 629
Natural history of aspirin-induced asthma
Szczeklik, A., Niżankowska, E., Duplaga, M., & the Aiane Investigators, O. B. O. (2000) · European Respiratory Journal · doi:10.1034/j.1399-3003.2000.016003432.x · Cited by 550
Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial
Bachert, C., Sousa, A. R., Lund, V. J., Scadding, G. K., Gevaert, P., Nasser, S., Durham, S. R., Cornet, M. E., Kariyawasam, H. H., Gilbert, J., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.05.044 · Cited by 505
Self-citationKowalski, M. L., Asero, R., Bavbek, S., Blanca, M., Blanca‐Lopez, N., Bochenek, G., Brockow, K., Campo, P., Celik, G., Cernadas, J., et al. (2013) · Allergy · doi:10.1111/all.12260 · Cited by 499
Self-citationSzczeklik, A., Gryglewski, R. J., & Czerniawska-Mysik, G. (1975) · BMJ · doi:10.1136/bmj.1.5949.67 · Cited by 484
Kowalski, M. L., Makowska, J. S., Blanca, M., Bavbek, S., Bochenek, G., Bousquet, J., Bousquet, P., Celik, G., Demoly, P., Gomes, E. R., et al. (2011) · Allergy · doi:10.1111/j.1398-9995.2011.02557.x · Cited by 465
Self-citationSystematic review of prevalence of aspirin induced asthma and its implications for clinical practice
Jenkins, C., Costello, J., & Hodge, L. (2004) · BMJ · doi:10.1136/bmj.328.7437.434 · Cited by 451
Rajan, J. P., Wineinger, N. E., Stevenson, D. D., & White, A. A. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.020 · Cited by 426
Self-citationEAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity
Niżankowska‐Mogilnicka, E., Bochenek, G., Mastalerz, L., Świerczyńska, M., Picado, C., Scadding, G., Kowalski, M. L., Setkowicz, M., Ring, J., Brockow, K., et al. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01409.x · Cited by 406
Self-citationDAHLÉN, B., NIZANKOWSKA, E., SZCZEKLIK, A., ZETTERSTRÖM, O., BOCHENEK, G., KUMLIN, M., MASTALERZ, L., PINIS, G., SWANSON, L. J., BOODHOO, T. I., et al. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707089 · Cited by 396
Self-citationSousa, A. R., Parikh, A., Scadding, G., Corrigan, C. J., & Lee, T. H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013508 · Cited by 373
Self-citationDAHLÉN, S.-E., MALMSTRÖM, K., NIZANKOWSKA, E., DAHLÉN, B., KUNA, P., KOWALSKI, M., LUMRY, W. R., PICADO, C., STEVENSON, D. D., BOUSQUET, J., et al. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.1.2010080 · Cited by 330
Self-citationPerez-Novo, C. A., Watelet, J. B., Claeys, C., Cauwenberge, P. V., & Bachert, C. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.02.029 · Cited by 279
Stevens, W. W., Peters, A. T., Hirsch, A. G., Nordberg, C. M., Schwartz, B. S., Mercer, D. G., Mahdavinia, M., Grammer, L. C., Hulse, K. E., Kern, R. C., et al. (2017) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2016.12.027 · Cited by 278
Phenotypes determined by cluster analysis in severe or difficult-to-treat asthma
Schatz, M., Hsu, J.-W. Y., Zeiger, R. S., Chen, W., Dorenbaum, A., Chipps, B. E., & Haselkorn, T. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.10.006 · Cited by 236
Prostaglandin D2: A dominant mediator of aspirin-exacerbated respiratory disease
Cahill, K. N., Bensko, J. C., Boyce, J. A., & Laidlaw, T. M. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.07.031 · Cited by 231
Self-citationMascia, K., Haselkorn, T., Deniz, Y. M., Miller, D. P., Bleecker, E. R., & Borish, L. (2005) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.08.035 · Cited by 223
Saline irrigation for chronic rhinosinusitis
Chong, L. Y., Head, K., Hopkins, C., Philpott, C., Glew, S., Scadding, G., Burton, M. J., & Schilder, A. G. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011995.pub2 · Cited by 186
Self-citationBuchheit, K. M., Cahill, K. N., Katz, H. R., Murphy, K. C., Feng, C., Lee-Sarwar, K., Lai, J., Bhattacharyya, N., Israel, E., Boyce, J. A., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.020 · Cited by 184
Self-citationKowalski, M. L., Ansotegui, I., Aberer, W., Al-Ahmad, M., Akdis, M., Ballmer-Weber, B. K., Beyer, K., Blanca, M., Brown, S., Bunnag, C., et al. (2016) · World Allergy Organization Journal · doi:10.1186/s40413-016-0122-3 · Cited by 163
Self-citationLiu, T., Kanaoka, Y., Barrett, N. A., Feng, C., Garofalo, D., Lai, J., Buchheit, K. M., Bhattacharya, N., Laidlaw, T. M., Katz, H. R., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500905 · Cited by 128
Self-citationSun, Y., Meng, Q., Scadding, G. K., Parikh, A., Corrigan, C. J., & Lee, T. H. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.10.037 · Cited by 124
Self-citationRagab, S. M., Parikh, A., Darby, Y., & Scadding, G. K. (2001) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2222.2001.01160.x · Cited by 122
Self-citationBankova, L. G., Lai, J., Yoshimoto, E., Boyce, J. A., Austen, K. F., Kanaoka, Y., & Barrett, N. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605957113 · Cited by 116
The effect of leukotriene‐modifier drugs on aspirin‐induced asthma and rhinitis reactions
Berges‐Gimeno, M. P., Simon, R. A., & Stevenson, D. D. (2002) · Clinical & Experimental Allergy · doi:10.1046/j.1365-2745.2002.01501.x · Cited by 107
Bochenek, G., Kuschill‐Dziurda, J., Szafraniec, K., Plutecka, H., Szczeklik, A., & Niżankowska‐Mogilnicka, E. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.07.004 · Cited by 103
Self-citationCardet, J. C., White, A. A., Barrett, N. A., Feldweg, A. M., Wickner, P. G., Savage, J. R. K., Bhattacharyya, N., & Laidlaw, T. M. (2014) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2013.12.003 · Cited by 91
Self-citationKowalski, M. L., Ptasinska, A., Jędrzejczak-Czechowicz, M., Bieńkiewicz, B., Cieślak, M., Grzegorczyk, J., Pawliczak, R., & DuBuske, L. M. (2005) · Allergy · doi:10.1111/j.1398-9995.2005.00836.x · Cited by 90
Self-citationMorales, D. R., Guthrie, B., Lipworth, B. J., Jackson, C., Donnan, P. T., & Santiago, V. H. (2015) · Allergy · doi:10.1111/all.12629 · Cited by 83
Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease.
Mullol, J., & Picado, C. (2013) · Immunology and allergy clinics of North America · doi:10.1016/j.iac.2012.11.002 · Cited by 75
Self-citationMastalerz, L., Nizankowska, E., Sanak, M., Mejza, F., Pierzchalska, M., Bazan‐Socha, S., Bestynska‐Krypel, A., Ćmiel, A., & Szczeklik, A. (2002) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2002.01088.x · Cited by 63
Self-citationLevy, J. M., Rudmik, L. R., Peters, A. T., Wise, S. K., Rotenberg, B. W., & Smith, T. L. (2016) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21826 · Cited by 58
Nasal lysine aspirin challenge in the diagnosis of aspirin ‐ exacerbated respiratory disease
Miller, B., Mirakian, R. M., Gane, S. B., Larco, J., Sannah, A. A., Darby, Y., & Scadding, G. K. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12110 · Cited by 48
Self-citationThe Role of Surgery in Management of Samter’s Triad
Adelman, J. P., McLean, C. C., Shaigany, K., & Krouse, J. H. (2016) · Otolaryngology · doi:10.1177/0194599816640723 · Cited by 45
Lee, H. Y., Ye, Y. ‐., Kim, S., Ban, G., Kim, S., Kim, J. H., Shin, Y. S., & Park, H. (2016) · Allergy · doi:10.1111/all.13075 · Cited by 45
Self-citationGenetics of Hypersensitivity to Aspirin and Nonsteroidal Anti-inflammatory Drugs
Kim, S., Sanak, M., & Park, H. (2012) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2012.10.003 · Cited by 43
Self-citationSaline irrigation for chronic rhinosinusitis
Chong, L. Y., Head, K., Hopkins, C. L., Philpott, C. M., & Schilder, A. G. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011995 · Cited by 42
Role of Group 2 Innate Lymphocytes in Aspirin-exacerbated Respiratory Disease Pathogenesis
White, A. A., & Doherty, T. A. (2018) · American Journal of Rhinology and Allergy · doi:10.2500/ajra.2018.32.4498 · Cited by 37
Self-citationAspirin-exacerbated respiratory disease: not always “adult-onset”
Tuttle, K. L., Schneider, T. R., Henrickson, S. E., Morris, D., Abonia, J. P., Spergel, J. M., & Laidlaw, T. M. (2016) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.05.016 · Cited by 36
Self-citationKowalski, M. L., & Makowska, J. S. (2006) · Treatments in Respiratory Medicine · doi:10.2165/00151829-200605060-00005 · Cited by 34
Self-citationAudit of nasal lysine aspirin therapy in recalcitrant aspirin exacerbated respiratory disease
Howe, R., Mirakian, R. M., Pillai, P., Gane, S. B., Darby, Y., & Scadding, G. K. (2014) · World Allergy Organization Journal · doi:10.1186/1939-4551-7-18 · Cited by 26
Self-citationAspirin-exacerbated respiratory disease
Pham, D. L., Lee, J.-H., & Park, H. (2016) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000328 · Cited by 23
Self-citationNonsteroidal anti‐inflammatory drugs–exacerbated respiratory disease in adolescents
Karagöl, H. İ. E., Yılmaz, Ö., Topal, E., Ceylan, A., & Bakırtaş, A. (2015) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21494 · Cited by 21
Pérez‐Alzate, D., Blanca‐López, N., Doña, I., Agúndez, J. A. G., García‐Martín, E., Cornejo-García, J. A., Perkins, J. R., Blanca, M., & Cantó, G. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00215 · Cited by 20
Self-citationAn epidemic of over diagnosing drug allergies
Stevenson, D. D., & Kowalski, M. L. (2014) · Allergy and Asthma Proceedings · doi:10.2500/aap.2014.35.1015 · Cited by 11
Self-citation
Cited by
International consensus statement on allergy and rhinology: rhinosinusitis 2021
Orlandi, R. R., Kingdom, T. T., Smith, T. L., Bleier, B., DeConde, A., Luong, A. U., Poetker, D. M., Soler, Z., Welch, K. C., Wise, S. K., et al. (2021) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22741 · Cited by 959
Self-citationERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Dumonceau, J.-M., Kapral, C., Aabakken, L., Papanikolaou, I. S., Tringali, A., Vanbiervliet, G., Beyna, T., Dinis-Ribeiro, M., Hritz, I., Mariani, A., et al. (2020) · Endoscopy · doi:10.1055/a-1075-4080 · Cited by 934
Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials
Gevaert, P., Omachi, T. A., Corren, J., Mullol, J., Han, J., Lee, S. E., Kaufman, D., Ligueros-Saylan, M., Howard, M., Zhu, R., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.032 · Cited by 739
Self-citationInternational consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Self-citationChronic Rhinosinusitis with Nasal Polyps and Asthma
Laidlaw, T. M., Mullol, J., Woessner, K. M., Amin, N., & Mannent, L. P. (2021) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2020.09.063 · Cited by 419
Self-citation
Metadata
- Authors
- Kowalski, M. L., Agache, I., Bavbek, S., Bakirtas, A., Blanca, M., Bochenek, G., Bonini, M., Heffler, E., Klimek, L., Laidlaw, T. M., Mullol, J., Niżankowska‐Mogilnicka, E., Park, H., Sanak, M., Sanchez‐Borges, M., Sanchez‐Garcia, S., Scadding, G., Taniguchi, M., Torres, M. J., White, A. A., & Wardzyńska, A.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2018-10-02
- Volume
- 74
- Issue
- 1
- Pages
- 28-39
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W2891218618
- Cited by
- 360
- References
- 50
- FWCI
- 19.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.